Clinical Trial Update: Estradiol and Testosterone Subdermal Implants for Menopause Treatment (ESTIME) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial (ESTIME) evaluating estradiol and testosterone subdermal implants for menopause treatment is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Estrogen Deficiency
• Hypogonadism
• Menopause

Drugs mentioned

• Estradiol subdermal implant (Estradiol)
• Testosterone subdermal implant (Testosterone)

Snippet

Sponsor: University of Sao Paulo General Hospital | Conditions: Menopause, Testosterone Deficiency | Phase 3 | Status: RECRUITING